ArriVent BioPharma will present initial safety and efficacy data from its Phase 1 study of ARR-217, a CDH17-targeted antibody-drug conjugate for gastrointestinal cancers, at the ESMO Congress 2026 in Madrid. The data will be shared in a rapid oral presentation on October 25, with a follow-up virtual webinar on October 26. ARR-217 targets a protein commonly overexpressed in colorectal and other gastrointestinal cancers, offering a promising new treatment approach. This presentation marks a key milestone in ArriVent's clinical development of novel cancer therapies.
ArriVent's upcoming presentation of Phase 1 data for its ADC ARR-217 in gastrointestinal cancers coincides with a mixed day for health-sector stocks on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 24, 2026 03:11 WIB: out of 150 priced US health stocks, 62 rose and 88 fell. Notable movers include AMLX at USD 27.26 with a 4.59% decline, ILMN at USD 270.00 down 4.55%, and HIMS at USD 27.84 down 4.43% with a Pluang order activity skewed 74% Sell to 26% Buy and a typical hold time of 22 days.
Remittix has raised $33 million and will burn 300 million RTX tokens, reducing supply by 20% ahead of public trading starting November 24, 2026. This token burn and near-cap funding boost scarcity and investor interest. Meanwhile, the XRP Ledger's No...
XTransfer, a leading global B2B cross-border payment platform, made its first appearance at Money20/20 USA 2026 in Las Vegas to accelerate its expansion into Latin American markets. The company recently completed regulatory registration in Chile, ena...
Kelvin Veras Real Estate completed 16 real estate transactions in its first year operating in New Jersey, including sales, purchases, rentals, and landlord services. This milestone highlights the company's successful market entry and diverse client s...
The documentary 'NURSE: Empathy Heals' premiered on October 21 in Nashville, showcasing personal stories of nurses and the critical role of empathy in healthcare. It highlights the emotional challenges nurses face, especially during crises like the C...
Oxford Square Capital Corp. announced it will hold a conference call on October 30, 2026, at 9:00 AM Eastern time to discuss its third quarter 2026 earnings. Investors can join the call via a toll-free number, and a recorded replay will be available ...
